# NEC Bio

Source: https://onco.cc/companies/nec-bio/  
OnCo record `nec-bio` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

NEC Bio is a Netherlands-based biotechnology company that leads 2 cancer trials in OnCo, testing the personalised neoantigen vaccine NECVAX-NEO1 in triple-negative breast cancer and advanced solid tumours.

## Summary

NEC Bio is the holding company set up by NEC Corporation in 2023 to unify its AI-driven drug discovery and development activities; it manages NEC OncoImmunity in Oslo and NEC Bio Therapeutics in Mannheim. The group applies its immune-recognition AI platform to personalised neoantigen cancer vaccines, including NECVAX-NEO1. It is a wholly owned subsidiary of NEC Corporation. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06631079 (phase 1/2, Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy...) and NCT06631092 (phase 1/2, Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-nega...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: NEC Bio B.V.; NEC OncoImmunity; NEC Bio Therapeutics
- Tags: ctgov-sponsor
- HQ: Schiphol
- Type: biotech
- Website: https://www.nec-bio.com/

## Sources

- Official website: https://www.nec-bio.com/
- ClinicalTrials.gov: trials led by NEC Bio: https://clinicaltrials.gov/search?lead=NEC%20Bio%20B.V

## Connected records

- cancers: [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- trials: [Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors](https://onco.cc/trials/nct06631079/), [Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer](https://onco.cc/trials/nct06631092/)

---
JSON: https://onco.cc/api/v1/entities/nec-bio.json